Maternal administration of anti-angiogenic agents, TNP-470 and Angiostatin(4.5), induces fetal microphthalmia

PURPOSE: Agents specifically targeting the vasculature as a mode of therapy are finding increasing use in the clinic, primarily in the treatment of colon cancer (Avastin™) and age-related macular degeneration (Lucentis™). We have previously shown that maternal administration of angiogenic inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutland, Catrin S., Jiang, Keyi, Soff, Gerald A., Mitchell, Christopher A.
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704144/
https://www.ncbi.nlm.nih.gov/pubmed/19572040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704144/
https://www.ncbi.nlm.nih.gov/pubmed/19572040

Ejemplares similares